MacLean Michael F
CIK 0001383731
Chief Financial OfficerDirector
Filings
25
Latest Apr 3, 2026
Issuers covered
3
Showing
25 of 25
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for MacLean Michael F. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where MacLean Michael F has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | 18 | Feb 27, 2026 |
| VERV | Verve Therapeutics, Inc. | 6 | Jul 28, 2025 |
| CAMP | Camp4 Therapeutics Corp | 1 | Apr 3, 2026 |
All filings
25 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|